PRESS RELEASE: MOLOGEN AG resolves capital increase from authorized capital

DGAP-News: MOLOGEN AG / Key word(s): Capital Increase MOLOGEN AG resolves capital increase from authorized capital

05.02.2014 / 21:53

=--------------------------------------------------------------------

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA.

MOLOGEN AG resolves capital increase from authorized capital

With the approval of the Supervisory Board and on the basis of the registered authorized capital the Management Board of MOLOGEN AG decided today to increase the share capital against cash contributions without subscription rights of the shareholders from currently EUR 15,419,512 to EUR 16,960,756 by issuing up to 1,541,244 new no-par value bearer shares with dividend rights from 1st January 2013. The proceeds from the capital increase will be used to further strengthen the equity base and in particular to finance the development of the product pipeline and the necessary ongoing research operations.

The new shares will be offered to European qualified investors in the context of a private placement. quirin bank AG, Berlin, accompanies the transaction as lead manager and bookrunner.

The placement starts today, 5 February 2014, and is expected to be completed tomorrow, 6 February 2014. MOLOGEN AG will set the issue price after the completion of a bookbuilding process and depending on the market situation at a discount of up to 5 per cent on the volume weighted average share price in Xetra trading during the last five trading days or on the in XETRA trading lastly determined stock price. The new shares shall be admitted to trading, without prospectus requirement, in the sub-segment of the regulated market with further post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange

Disclaimer:

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities.

Link:
PRESS RELEASE: MOLOGEN AG resolves capital increase from authorized capital

Related Posts

Comments are closed.